AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
READINESS OF HIGH-RISK POPULATIONS IN THE HIV NETWORK FOR PREVENTION TRIALS TO PARTICIPATE IN HIV VACCINE EFFICACY TRIALS IN THE UNITED-STATES
Authors: KOBLIN BA HEAGERTY P SHEON A BUCHBINDER S CELUM C DOUGLAS JM GROSS M MARMOR M MAYER K METZGER D SEAGE G
Citation: Ba. Koblin et al., READINESS OF HIGH-RISK POPULATIONS IN THE HIV NETWORK FOR PREVENTION TRIALS TO PARTICIPATE IN HIV VACCINE EFFICACY TRIALS IN THE UNITED-STATES, AIDS, 12(7), 1998, pp. 785-793
HIV VACCINE TRIALS
Authors: DESJARLAIS DC VANICHSENI S MARMOR M KITAYAPORN D
Citation: Dc. Desjarlais et al., HIV VACCINE TRIALS, Science, 279(5356), 1998, pp. 1433-1434
WHY I AM NOT INFECTED WITH HIV - IMPLICATIONS FOR LONG-TERM HIV RISK REDUCTION AND HIV VACCINE TRIALS
Authors: DESJARLAIS DC VANICHSENI S MARMOR M BUAVIRAT A TITUS S RAKTHAM S FRIEDMANN P KITAYAPORN D WOLFE H FRIEDMAN SR MASTRO TD
Citation: Dc. Desjarlais et al., WHY I AM NOT INFECTED WITH HIV - IMPLICATIONS FOR LONG-TERM HIV RISK REDUCTION AND HIV VACCINE TRIALS, Journal of acquired immune deficiency syndromes and human retrovirology, 16(5), 1997, pp. 393-399
GEOGRAPHIC DIVERSITY IN TUBERCULOSIS TRENDS AND DIRECTLY OBSERVED THERAPY, NEW-YORK-CITY, 1991 TO 1994
Authors: DAVIDOW AL MARMOR M ALCABES P
Citation: Al. Davidow et al., GEOGRAPHIC DIVERSITY IN TUBERCULOSIS TRENDS AND DIRECTLY OBSERVED THERAPY, NEW-YORK-CITY, 1991 TO 1994, American journal of respiratory and critical care medicine, 156(5), 1997, pp. 1495-1500
LOW SERUM THIOL LEVELS PREDICT SHORTER TIMES-TO-DEATH AMONG HIV-INFECTED INJECTING DRUG-USERS
Authors: MARMOR M ALCABES P TITUS S FRENKEL K KRASINSKI K PENN A PERO RW
Citation: M. Marmor et al., LOW SERUM THIOL LEVELS PREDICT SHORTER TIMES-TO-DEATH AMONG HIV-INFECTED INJECTING DRUG-USERS, AIDS, 11(11), 1997, pp. 1389-1393
REEXAMINATION OF HUMAN T-CELL LYMPHOTROPIC VIRUS (HTLV-I II) PREVALENCE/
Authors: ZUCKERFRANKLIN D PANCAKE BA MARMOR M LEGLER PM
Citation: D. Zuckerfranklin et al., REEXAMINATION OF HUMAN T-CELL LYMPHOTROPIC VIRUS (HTLV-I II) PREVALENCE/, Proceedings of the National Academy of Sciences of the United Statesof America, 94(12), 1997, pp. 6403-6407
DETERMINATION OF THE TRUE PREVALENCE OF INFECTION WITH THE HUMAN T-CELL LYMPHOTROPIC VIRUSES (HTLV-I II) MAY REQUIRE A COMBINATION OF BIOMOLECULAR AND SEROLOGICAL ANALYSES/
Authors: PANCAKE BA ZUCKERFRANKLIN D MARMOR M LEGLER PM
Citation: Ba. Pancake et al., DETERMINATION OF THE TRUE PREVALENCE OF INFECTION WITH THE HUMAN T-CELL LYMPHOTROPIC VIRUSES (HTLV-I II) MAY REQUIRE A COMBINATION OF BIOMOLECULAR AND SEROLOGICAL ANALYSES/, Proceedings of the Association of American Physicians, 108(6), 1996, pp. 444-448
DETERMINATION OF THE TRUE PREVALENCE OF INFECTION WITH THE HUMAN T-CELL LYMPHOTROPIC VIRUSES (HTLV-I II) MAY REOUIRE A COMBINATION OF BIOMOLECULAR AND SEROLOGIC ANALYSES/
Authors: PANCAKE BA ZUCKERFRANKLIN D MARMOR M
Citation: Ba. Pancake et al., DETERMINATION OF THE TRUE PREVALENCE OF INFECTION WITH THE HUMAN T-CELL LYMPHOTROPIC VIRUSES (HTLV-I II) MAY REOUIRE A COMBINATION OF BIOMOLECULAR AND SEROLOGIC ANALYSES/, Journal of investigative medicine, 44(3), 1996, pp. 250-250
WEIGHT-LOSS ASSOCIATED WITH HIV SEROCONVERSION AMONG INJECTION-DRUG USERS
Authors: MARMOR M TITUS S HARRISON C CORDCRUZ EA SHORE RE VOGLER M KRASINSKI K MILDVAN D JARLAIS DCD
Citation: M. Marmor et al., WEIGHT-LOSS ASSOCIATED WITH HIV SEROCONVERSION AMONG INJECTION-DRUG USERS, Journal of acquired immune deficiency syndromes and human retrovirology, 12(5), 1996, pp. 514-518
METHADONE-MAINTENANCE AND OTHER FACTORS ASSOCIATED WITH INTRAINDIVIDUAL TEMPORAL TRENDS IN INJECTION-DRUG USE
Authors: SHORE RE MARMOR M TITUS S DESJARLAIS DC
Citation: Re. Shore et al., METHADONE-MAINTENANCE AND OTHER FACTORS ASSOCIATED WITH INTRAINDIVIDUAL TEMPORAL TRENDS IN INJECTION-DRUG USE, Journal of substance abuse treatment, 13(3), 1996, pp. 241-248
HIV INCIDENCE AMONG INJECTING DRUG-USERS IN NEW-YORK-CITY SYRINGE-EXCHANGE PROGRAMS
Authors: JARLAIS DCD MARMOR M PAONE D TITUS S SHI QH PERLIS T JOSE B FRIEDMAN SR
Citation: Dcd. Jarlais et al., HIV INCIDENCE AMONG INJECTING DRUG-USERS IN NEW-YORK-CITY SYRINGE-EXCHANGE PROGRAMS, Lancet, 348(9033), 1996, pp. 987-991
AN UNRECORDED MANUSCRIPT TRANSLATION OF PHILANDER 'DIGRESSIO UTILISSIMO' ON THE CLASSICAL ORDERS AND THE 'GENEVA VITRUVIUS' OF 1618
Authors: MITCHELL H MARMOR M
Citation: H. Mitchell et M. Marmor, AN UNRECORDED MANUSCRIPT TRANSLATION OF PHILANDER 'DIGRESSIO UTILISSIMO' ON THE CLASSICAL ORDERS AND THE 'GENEVA VITRUVIUS' OF 1618, Journal of the Society of Architectural Historians, 55(2), 1996, pp. 152-157
EVALUATION OF CONTRACTILE RESERVE BY DOBUTAMINE ECHOCARDIOGRAPHY - NONINVASIVE ESTIMATION OF THE SEVERITY OF HEART-FAILURE
Authors: MARMOR A RAPHAEL T MARMOR M BLONDHEIM D
Citation: A. Marmor et al., EVALUATION OF CONTRACTILE RESERVE BY DOBUTAMINE ECHOCARDIOGRAPHY - NONINVASIVE ESTIMATION OF THE SEVERITY OF HEART-FAILURE, The American heart journal, 132(6), 1996, pp. 1195-1201
COMMUNITY-BASED HEROIN-ADDICTS WHO TURN TO EXPERIMENTAL TREATMENT RATHER THAN CONVENTIONAL CARE
Authors: MICHAELS J GALANTER M RESNICK R MARMOR M LIFSHUTZ H PERRONE R
Citation: J. Michaels et al., COMMUNITY-BASED HEROIN-ADDICTS WHO TURN TO EXPERIMENTAL TREATMENT RATHER THAN CONVENTIONAL CARE, Journal of addictive diseases, 14(2), 1995, pp. 33-42
A NEW METHODOLOGY FOR NONINVASIVE CLINICAL-ASSESSMENT OF CARDIOVASCULAR-SYSTEM PERFORMANCE AND OF VENTRICULAR-ARTERIAL COUPLING DURING STRESS
Authors: NEVO F MARMOR M LANIR Y WEISS TA MARMOR A
Citation: F. Nevo et al., A NEW METHODOLOGY FOR NONINVASIVE CLINICAL-ASSESSMENT OF CARDIOVASCULAR-SYSTEM PERFORMANCE AND OF VENTRICULAR-ARTERIAL COUPLING DURING STRESS, Heart and vessels, 10(1), 1995, pp. 24-34
PROGRESS IN IDENTIFYING CLINICAL RELEVANCE OF INHIBITION, STIMULATIONAND MEASUREMENTS OF POLY ADP-RIBOSYLATION
Authors: PERO RW OLSSON A SHENG Y HUA J MOLLER C KJELLEN E KILLANDER D MARMOR M
Citation: Rw. Pero et al., PROGRESS IN IDENTIFYING CLINICAL RELEVANCE OF INHIBITION, STIMULATIONAND MEASUREMENTS OF POLY ADP-RIBOSYLATION, Biochimie, 77(5), 1995, pp. 385-393
EVIDENCE FOR AN EFFECT OF HUMAN-LEUKOCYTE ANTIGENS ON SUSCEPTIBILITY TO KAPOSIS-SARCOMA RELATED TO CHARGE AND PEPTIDE-BINDING PROPERTIES OFCLASS-I MOLECULES
Authors: MARMOR M WINCHESTER R ZELENIUCHJACQUOTTE A WEISS SH KRASINSKI K SAXINGER WC FRIEDMANKIEN A WILLIAMS DC DEMOPOULOS R
Citation: M. Marmor et al., EVIDENCE FOR AN EFFECT OF HUMAN-LEUKOCYTE ANTIGENS ON SUSCEPTIBILITY TO KAPOSIS-SARCOMA RELATED TO CHARGE AND PEPTIDE-BINDING PROPERTIES OFCLASS-I MOLECULES, AIDS, 9(10), 1995, pp. 1194-1195
TUBERCULOSIS KNOWLEDGE AMONG NEW-YORK-CITY INJECTION-DRUG USERS
Authors: WOLFE H MARMOR M MASLANSKY R NICHOLS S SIMBERKOFF M DESJARLAIS D MOSS A
Citation: H. Wolfe et al., TUBERCULOSIS KNOWLEDGE AMONG NEW-YORK-CITY INJECTION-DRUG USERS, American journal of public health, 85(7), 1995, pp. 985-988
RISK-FACTORS FOR CHOROIDAL NEOVASCULARIZATION IN YOUNG-PATIENTS - A CASE-CONTROL STUDY
Authors: DEROSA JT YANNUZZI LA MARMOR M FOTINO M SORENSON JA SPAIDE RF
Citation: Jt. Derosa et al., RISK-FACTORS FOR CHOROIDAL NEOVASCULARIZATION IN YOUNG-PATIENTS - A CASE-CONTROL STUDY, Documenta ophthalmologica, 91(3), 1995, pp. 207-222
IRIS MELANOMA IN A 10-YEAR-OLD BOY WITH FAMILIAL ATYPICAL MOLE-MELANOMA (FAM-M) SYNDROME
Authors: SINGH AD SHIELDS JA EAGLE RC SHIELDS CL MARMOR M DEPOTTER P
Citation: Ad. Singh et al., IRIS MELANOMA IN A 10-YEAR-OLD BOY WITH FAMILIAL ATYPICAL MOLE-MELANOMA (FAM-M) SYNDROME, Ophthalmic genetics, 15(3-4), 1994, pp. 145-149
BLEACH USE AND HIV SEROCONVERSION AMONG NEW-YORK-CITY INJECTION-DRUG USERS
Authors: TITUS S MARMOR M DESJARLAIS D KIM M WOLFE H BEATRICE S
Citation: S. Titus et al., BLEACH USE AND HIV SEROCONVERSION AMONG NEW-YORK-CITY INJECTION-DRUG USERS, Journal of acquired immune deficiency syndromes, 7(7), 1994, pp. 700-704
REVERSAL-LEARNING TASKS MAY PROVIDE RAPID-DETERMINATION OF COGNITIVE DEFICITS IN LEAD-EXPOSED CHILDREN
Authors: EVANS HL DANIEL SA MARMOR M
Citation: Hl. Evans et al., REVERSAL-LEARNING TASKS MAY PROVIDE RAPID-DETERMINATION OF COGNITIVE DEFICITS IN LEAD-EXPOSED CHILDREN, Neurotoxicology and teratology, 16(5), 1994, pp. 471-477
PREPARATIONS FOR AIDS VACCINE TRIALS - RETENTION, BEHAVIOR-CHANGE, AND HIV-SEROCONVERSION AMONG INJECTING DRUG-USERS (IDUS) AND SEXUAL PARTNERS OF IDUS
Authors: MARMOR M TITUS S WOLFE H KRASINSKI K MASLANSKY R SIMBERKOFF M BEATRICE S NICHOLS S DESJARLAIS DC
Citation: M. Marmor et al., PREPARATIONS FOR AIDS VACCINE TRIALS - RETENTION, BEHAVIOR-CHANGE, AND HIV-SEROCONVERSION AMONG INJECTING DRUG-USERS (IDUS) AND SEXUAL PARTNERS OF IDUS, AIDS research and human retroviruses, 10, 1994, pp. 190000207-190000213
ESTIMATION OF TIME SINCE INFECTION USING LONGITUDINAL DISEASE-MARKER DATA
Authors: DUBIN N BERMAN S MARMOR M TINDALL B DESJARLAIS D KIM M
Citation: N. Dubin et al., ESTIMATION OF TIME SINCE INFECTION USING LONGITUDINAL DISEASE-MARKER DATA, Statistics in medicine, 13(3), 1994, pp. 231-244
CONTINUITY AND CHANGE WITHIN AN HIV EPIDEMIC - INJECTING DRUG-USERS IN NEW-YORK-CITY, 1984 THROUGH 1992
Authors: JARLAIS DCD FRIEDMAN SR SOTHERAN JL WENSTON J MARMOR M YANCOVITZ SR FRANK B BEATRICE S MILDVAN D
Citation: Dcd. Jarlais et al., CONTINUITY AND CHANGE WITHIN AN HIV EPIDEMIC - INJECTING DRUG-USERS IN NEW-YORK-CITY, 1984 THROUGH 1992, JAMA, the journal of the American Medical Association, 271(2), 1994, pp. 121-127
Risultati: 1-25 | 26-34